Roche Holding AG

Swiss Stock Exchange:RO.SW

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🩺 Medical Instruments

Location

Switzerland

Market Cap

USD 262.85 B

Share Price

USD 347.50

Avg Daily Volume

39,406

Change (1 day)

0.20%

Change (1 year)

13.47%

Change (YTD)

16.14%

Roche Holding AG Free Cash Flow Yield on June 27, 2025: 6.32%

Roche Holding AG Free Cash Flow Yield is 6.32% on June 27, 2025, a 3.45% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Roche Holding AG 52-week low Free Cash Flow Yield is 7.41% on June 27, 2025, which is 17.28% above the current Free Cash Flow Yield.
Roche Holding AG 52-week low Free Cash Flow Yield is 5.00% on June 27, 2025, which is -20.91% below the current Free Cash Flow Yield.
Roche Holding AG average Free Cash Flow Yield for the last 52 weeks is 5.83%.

Daily

From:

To:

Zoom:

Key data

Date	Free Cash Flow Yield	Dividend Yield	Market Capitalization	Share Price

Swiss Stock Exchange: RO.SW

Roche Holding AG

CEO	Dr. Thomas Schinecker
IPO Date	Aug. 3, 1995
Location	Switzerland
Headquarters	Konzern Hauptsitz
Employees	103,249
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🩺 Medical Instruments

Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.